New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2014
08:40 EDTMDXGMiMedx EpiFix allograft awarded coverage by HCSC
MiMedx Group announced that Health Care Services Corporation, HCSC, has confirmed that the company's EpiFix allograft has been awarded reimbursement coverage. HCSC has approved the reimbursement of EpiFix for the indications as prescribed by the physician, including wound care, soft tissue replacement or repairs in burns, cardiovascular applications, treatment of ocular surfaces, and the application as a surgical barrier in knee or spine surgeries. The company also reported that its EpiFix allograft currently has reimbursement approval from 12 state Medicaid Programs.
News For MDXG From The Last 14 Days
Check below for free stories on MDXG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 7, 2014
08:47 EDTMDXGMiMedx reports Q1 revenue slightly exceeded upper end of guidance
Q1 guidance was $18M-$19.5M. Q1 consensus of $19.09M. March revenue, in particular, grew significantly. The company expects a minimal amount of the confusion experienced in the first quarter will continue for a portion of the second quarter and then dissipate during the second quarter.
08:33 EDTMDXGMiMedx backs FY14 revenue $95M-$110M, consensus $99.67M
08:33 EDTMDXGMiMedx sees Q2 revenue $21.5M-$23.5M, consensus $19.09M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use